The American Society for Reproductive Medicine is pleased to announce the availability of a limited number of awards to support the travel of trainees who are presenting abstracts at the 2013 IFFS/ASRM conjoint meeting in Boston. These awards are made possible through the generous support of the ASRM Board of Directors and the ASRM Corporate Member Council. Congratulations to the 2012 Award Winners!
- 15 awards of $1,500 USD to trainee abstract presenters from the United States
- 15 awards of $2,000 USD to trainee abstract presenters from countries outside the United States*
- Must be an undergraduate, graduate, medical or allied health professions student, postdoctoral trainee, or clinical resident or fellow.
- Must be the first and presenting author of the abstract.
- Abstract must have been selected for oral or poster presentation in the ASRM 2013 Scientific Program.
- Applicants must check the box on the abstract submission site indicating their desire to be considered for an award.
- By June 1, 2013, applicants must submit a curriculum vitae, including current educational program, as a single electronic pdf file to email@example.com.
- Recipients will be notified by email by July 1, 2013.
- Payment will be made at the time of the Annual Meeting.
- Applications will be reviewed by the ASRM Research Committee.
- Selection will be based on scientific merit of the abstract and qualifications of the presenter.
- Questions regarding eligibility, application, payment, etc., should be directed to Dr. Andrew R. La Barbera, ASRM Scientific Director, at firstname.lastname@example.org.
**Residents of the following countries are NOT eligible for the international awards: Andorra, Aruba, Australia, Austria, Bahamas, Bahrain, Barbados, Belgium, Bermuda, Brunei Darussalam, Canada, Cayman Islands, Channel Islands, China, Croatia, Curaçao, Cyprus, Czech Republic, Denmark, Equatorial Guinea, Estonia, Faeroe Islands, Finland, France, French Polynesia, Germany, Greece, Greenland, Guam, Hungary, Iceland, Ireland, Isle of Man, Israel, Italy, Japan, Korea, Kuwait, Liechtenstein, Luxembourg, Macao SAR, Malta, Monaco, Netherlands, New Caledonia, New Zealand, Northern Mariana Islands, Norway, Oman, Poland, Portugal, Puerto Rico, Qatar, Rep. St. Kitts and Nevis, San Marino, Saudi Arabia, Singapore, Sint Maarten, Slovak Republic, Slovenia, Spain, St. Martin, Sweden, Switzerland, The Hong Kong SAR, Trinidad and Tobago, Turks and Caicos Islands, United Arab Emirates, United Kingdom, Virgin Islands (U.S.)
Congratulations to the 2012 Award Winners:
O-5, Monday, October 22, 2012, 12:15 PM
MACAQUE OVARIAN TISSUE VITRIFIED IN A CLOSED SYSTEM YIELDS FUNCTIONAL SECONDARY FOLLICLES
A. Y. Ting, R. R. Yeoman, J. R. Campos, M. S. Lawson, M. B. Zelinski. Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR.
O-25, Monday, October 22, 2012, 4:45 PM
INFERTILITY AND THE UTILIZATION OF INFERTILITY TREATMENT IN FEMALE SURVIVORS OF CHILDHOOD CANCER: A REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY
S. E. Barton1, J. Najita2, E. S. Ginsburg1, L. R. Diller3. 1Division of Reproductive Medicine; Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston, MA; 2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; 3Department of Pediatric Oncology, Dana-Farber Childrens Hospital Cancer Center, Boston, MA.
O-224, Wednesday, October 24, 2012, 11:30 AM
A PROSPECTIVE STUDY OF ENDOMETRIOSIS AND CORONARY HEART DISEASE RISK
F. Mu1, J. Rich-Edwards2, E. Rimm3, K. Mukamal4, S. Missmer5. 1Department of Epidemiology, Harvard School of Public Health, Boston, MA; 2Connors Center for Women’s Health, Brigham and Women’s Hospital, Boston, MA; 3Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; 4Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA; Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA.
O-115, Tuesday, October 23, 2012, 4:15 PM
EVALUATION OF OVARIAN AND TESTICULAR TISSUE CRYOPRESERVATION AND THEIR BUNDLING WITH MEDICALLY-INDICATED PROCEDURES IN CHILDREN UNDERGOING GONADOTOXIC THERAPIES FOR BLOOD DYCRASIAS OR CANCER
S. Babayev1, M. Karsy1, E. Arslan1,2, S. Kogan2,3, K. Oktay1. 1Obstetrics and Gynecology, New York Medical College, Valhalla, NY; 2Institute for Fertility Preservation and Reproductive Surgery of New York, Rye, NY; Urology, New York Medical College, Valhalla, NY.
O-117, Tuesday, October 23, 2012, 4:45 PM
LAPAROSCOPIC TUBAL REANASTOMOSIS VERSUS IN VITRO FERTILIZATION: COST-BASED DECISION ANALYSIS INCOPORATING MULTIPLE PATIENT AGES, LIGATION TECHNIQUE AND IMPACT OF MULTIPLE GESTATION
J. A. Winter, J. E. Hirshfeld-Cytron. Obstetrics and Gynecology, University of Illinois Medical Center, Chicago, IL.
O-299, Wednesday, October 24, 2012, 3:45 PM
ICE BLOCKERS IMPROVE VITRIFICATION OUTCOME OF MOUSE EMBRYOS BY ALLOWING LOWER CRYOPROTECTANT CONCENTRATION IN VITRIFICATION MEDIA WITHIN A CLOSED SYSTEM
T. A. Farghaly1,2, S. Israel1, M. Marconi1, A. Loeb1, J. Goldfarb1, A. Ahmady1. 1University Hospitals Fertility Center, Ahuja Medical Center, Beachwood, OH; 2Womens’ Health Center, Assiut University, Assiut, Egypt.
O-231, Wednesday, October 24, 2012, 11:30 AM
SPHINGOSINE-1-PHOSPHATE PREVENTS HUMAN PRIMORDIAL FOLLICLE DEATH INDUCED BY A DIVERSE SET OF CHEMOTHERAPY AGENTS
F. Li1, K. Akula1, E. Ozkaya1, P. De Sutter3, K. Oktay1,2. 1Laboratory of Molecular Reproduction and Fertility Preservation, Obstetrics & Gynecology, New York Medical College, Valhalla, NY; 2Institute for Fertility Preservation and Reproductive Specialists of New York, Rye, NY; 3Department of Reproductive Medicine, Ghent University, Ghent, Belgium.
O-12, Monday, October 22, 2012, 5:30 PM
A SHORTER FOLLICULAR PHASE DOES NOT HAVE A DELETERIOUS EFFECT ON THE OUTCOME OF OVULATION INDUCTION/INTRAUTERINE INSEMINATION (OI/IUI) CYCLES
A. N. Imudia, I. Dimitriadis, J. C. Petrozza, I. Souter. Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital Fertility Center, Boston, MA.
O-161, Tuesday, October 23, 2012, 4:15 PM
BLASTOCYST EUPLOID SELECTIVE TRANSFER (BEST): AN RCT OF COMPREHENSIVE CHROMOSOME SCREENING –SINGLE EMBRYO TRANSFER (CCS-SET) VS DOUBLE EMBRYO TRANSFER (DET) – EQUIVALENT PREGNANCY RATES, ELIMINATES TWINS
E. J. Forman1,2, K. H. Hong1,2, K. M. Ferry1,2, X. Tao1, N. R. Treff1,2,3, R. T. Scott, Jr.1,2. 1Reproductive Endocrinology, Reproductive Medicine Associates of New Jersey, Morristown, NJ; 2Obstetrics, Gynecology and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ; 3Genetics, Rutgers-The State University of New Jersey, Piscataway, NJ.
O-272, Wednesday, October 24, 2012, 11:15 AM
ALTERATIONS IN THE SPERM PROTEOME MAY IDENTIFY IDIOPATHIC INFERTILITY AND POOR IVF OUTCOME
S. McReynolds1, M. Dzieciatkowska2, K. C. Hansen2, M. Katz-Jaffe1,3. 1National Foundation for Fertility Research, Lone Tree, CO; 2University of Colorado Denver, Aurora, CO; 3Colorado Center for Reproductive Medicine, Lone Tree, CO.
O-55, Monday, October 22, 2012, 4:45 PM
THE USE OF CUMULUS CELL (CC) mRNA LEVELS TO PREDICT BLASTOCYST DEVELOPMENT AND LIVE BIRTH OUTCOMES IN WOMEN UNDERGOING INTRACYTOPLASMIC SPERM INJECTION (ICSI) AND SINGLE EMBRYO TRANSFER
J. Ekart1,2, J. D. Hutton2, K. P. McNatty1, K. Coetzee2, J. L. Pitman1. 1Victoria University of Wellington, Wellington, WGT, New Zealand; 2Fertility Associates Ltd, Wellington, WGT, New Zealand.
O-147, Tuesday, October 23, 2012, 4:45 PM
PRACTICING COGNITIVE BEHAVIORAL INTERVENTIONS (CBI) INCREASES PREGNANCY RATES IN WOMEN UNDERGOING IVF
J. Czamanski-Cohen1, O. Sarid1, J. Cwikel1, A. Zeadna2, E. Levitas1,2, I. Har-Vardi1,2. 1Ben Gurion University of the Negev, Beer Sheeba, Israel; 2Soroka University Medical Center, Beer Sheeba, Israel.
O-318, Wednesday, October 24, 2012, 4:30 PM
FERTILITY PRESERVATION WITH IVF OR IVM FOR WOMEN WITH HEMATOLOGICAL MALIGNANCY – EXPERENCES AND EXPECTATIONS
J. H. Hyman, J.-T. Chung, T. Sokal-Arnon, E. Shalom-Paz, A. Wiser, H. Holzer. MUHC Reproductive Centre, Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada.
O-73, Monday, October, 22, 2012, 5:15 PM
THE EXPRESSION PATTERN OF STAGE SPECIFIC-GERM CELL MARKERS IN SEMINIFEROUS TUBULE INJECTED WITH SPERMATOGONIAL STEM CELLS DURING IN VITRO SPERMATOGENESIS
H. J. Kim, Y. J. Cho, J. J. Lim, S.-H. Song, T. K. Yoon, D. R. Lee. Fertility Center of CHA Gangnam Medical Center, CHA Research Institute, Seoul, Republic of Korea.
VITRIFICATION OF BOVINE OOCYTES SUBSTANTIALLY IMPAIRS THEIR REPRODUCTIVE CAPACITY INDEPENDENTLY OF MATURATION STAGE
D. L. Bulgarelli, A. A. Vireque, C. P. Pitangui, M. P. Bernuci, M. F. Silva-de-Sá, A. C. Sá Rosa-e-Silva. Department of Obstetrics and Gynecology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.